LOFIEGO MARIA FORTUNATA | Elenco docenti

Lofiego, M.F., Piazzini, F., Caruso, F.P., Marzani, F., Solmonese, L., Bello, E., et al. (2024). Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches. JOURNAL OF TRANSLATIONAL MEDICINE, 22(1) [10.1186/s12967-024-05040-x]. - dettaglio
Calabrò, L., Bronte, G., Grosso, F., Cerbone, L., Delmonte, A., Nicolini, F., et al. (2024). Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream. FRONTIERS IN IMMUNOLOGY, 14 [10.3389/fimmu.2023.1333661]. - dettaglio
Noviello, T.M.R., Di Giacomo, A.M., Caruso, F.P., Covre, A., Mortarini, R., Scala, G., et al. (2023). Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial. NATURE COMMUNICATIONS, 14(1) [10.1038/s41467-023-40994-4]. - dettaglio
Anichini, A., Molla, A., Nicolini, G., Perotti, V.E., Sgambelluri, F., Covre, A., et al. (2022). Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 41(1), 1-15 [10.1186/s13046-022-02529-5]. - dettaglio
Di Giacomo, A.M., Giacobini, G., Anichini, G., Gandolfo, C., D'Alonzo, V., Calabro, L., et al. (2022). SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines. EUROPEAN JOURNAL OF CANCER, 171, 143-149 [10.1016/j.ejca.2022.05.018]. - dettaglio

Tutte le pubblicazioni